# A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease

> **NCT02453061** · PHASE2 · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 100 (actual)

## Conditions studied

- Huntington Disease

## Interventions

- **DRUG:** Triheptanoin oil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02453061
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-29
- **Primary completion:** 2019-12-03
- **Final completion:** 2019-12-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02453061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02453061, "A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02453061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*